Evaluation of quantitative levels of anti-PGL-Tb1 and anti-ESAT-6/CFP10 antibodies (medians) in individuals with varying risk of latent tuberculosis infection stratified by the center of enrolment.

Footnotes: N = number of serum tested; NA: not applicable because no individual has been recruited at that center;* p<0.01.